English
中文
Español
Search
New Chat
Hot Signals
Calendar
Agents
Market
Events
Download App
Language
AZN Market Pulse Today
208 News
AstraZeneca Climbs 1.47% to $188.41 Amid New YMCA Partnership and Positive Analyst Upgrades
1 day ago
AstraZeneca Gains 1.45% on Strong Earnings and $2 Billion Manufacturing Expansion Announcement
2 days ago
AstraZeneca Gains 1.10% Amid Mixed News on Regulatory Approval and Trial Setback
3 days ago
AstraZeneca Stock Climbs 2.60% to $181.02 Amid Broader Market Decline
4 days ago
AstraZeneca Gains 1.21% on U.S. Approval of Prostate Cancer Treatment Truqap
5 days ago
AstraZeneca (AZN) Stock Drops 1.5% Amid Market Volatility and Mixed Analyst Ratings
Jun. 19
AstraZeneca Stock Dips 0.46% to Close at $177.89 Amid Active Trading
Jun. 18
AstraZeneca (AZN) Gains 0.81% with Steady Trading on June 17, 2026
Jun. 17
AstraZeneca Falls 1.94% to $178.75 Amid Mixed Earnings and Regulatory Challenges
Jun. 13
AstraZeneca Rises 1.86% to $182.28 Amid Positive Clinical Trial News
Jun. 12
AstraZeneca Stock Drops 2.44% Amid Market Pressure Despite Positive Drug Trial News
Jun. 11
AstraZeneca Shares Plunge 2.37% Amid FDA Review Delay for Key Breast Cancer Drug
Jun. 09
AstraZeneca Climbs 2.28% to Close at $185.95 Amid Positive FDA News and Strong Earnings
Jun. 06
AstraZeneca Shares Dip 0.66% to Close at $176.28 Amid Moderate Trading Volume
Jun. 04
AstraZeneca Stock Drops 1.26% to Close at $177.45 Amid Market Volatility
Jun. 03
AstraZeneca Shares Drop 3.21% Amidst Broader Market Sentiment on June 1, 2026
Jun. 02
AstraZeneca Drops 1.43% Despite FDA Approval of Datroway and Positive Clinical Trial Results
May. 23
AstraZeneca Stock Climbs 1.22% Following FDA Approval for Enhertu and Positive Investor Day
May. 22
AstraZeneca Gains 1.24% to Close at 13,880.00 GBX Amid FDA Drug Approvals
May. 20
AstraZeneca Stock Climbs 1.29% on FDA Approval of Enhertu and Strong Q1 Earnings
May. 19
Load More
NextFin.Al
No Noise, only Signal.
Open App
